logo
Meet the leaders of MBB, the consulting giants advising the world's most powerful CEOs

Meet the leaders of MBB, the consulting giants advising the world's most powerful CEOs

Business Insider8 hours ago
You might not know their names, but they likely have the ear of many powerful CEOs.
They're the leaders of what are widely considered the most prestigious strategy consulting firms: McKinsey & Company, Bain & Company, and Boston Consulting Group, which are collectively referred to as the Big 3, or MBB.
MBB firms are often tough places to land a job, and their consultants are some of the most sought-after in the industry.
They're the people tech giants like Microsoft, Amazon, and Apple — as well as government agencies — turn to for advice on things like mergers and acquisitions, business strategy, and AI adoption. MBB consultants have also gone on to lead some of the world's biggest companies.
So, who's leading the nearly hundred thousand employees across these influential firms?
Here's a look at the leaders at McKinsey, Bain, and BCG.
McKinsey — Bob Sternfels
Bob Sternfels is the global managing partner and chair of the board of directors at McKinsey, which is headquartered in New York City and has offices around the world. The firm employs about 40,000 people.
Senior partners first elected Sternfels in 2021 and re-elected him to a second three-year term in 2024.
Sternfels grew up in California's Central Valley and has worked at McKinsey since 1994, when he joined the San Francisco office. Prior to becoming global managing partner, he led McKinsey's client capabilities around the world. Before that, he ran the operations practice for the Americas and the private equity and principal investors practice globally.
He studied economics and history at Stanford University, where he also played Division I varsity water polo. Sternfels has said on several occasions that his sports background has influenced his leadership style. He got his master's in politics, philosophy, and economics at the University of Oxford, where he was a Rhodes Scholar.
Sternfels recently told Business Insider that humor and vulnerability are some of his key leadership tools. He also said he likes to take small groups on walks when visiting McKinsey offices because it can help folks open up.
"A little levity — a joke at your own expense, a lighthearted moment — can go a long way toward building trust, breaking down barriers, and democratizing the team room," he said.
When he was elected global managing partner, the firm said Sternfels was often described as organized, proactive, and a systems thinker.
Under his leadership, McKinsey has navigated the AI revolution, launching QuantumBlack, the firm's AI consulting arm.
During his tenure, McKinsey has also faced scrutiny for earlier advising Purdue Pharma on how to boost sales of OxyContin. Sternfels testified before Congress in 2022, and the firm has paid about $1.6 billion in recent years to settle legal claims.
McKinsey has also recently reduced its staff by 10%, BI reported in May. The firm said at the time that the reorganization was in part due to AI driving new levels of efficiency and that it planned to hire thousands of new consultants in 2025.
Bain & Company — Christophe De Vusser
Christophe De Vusser is the worldwide managing partner, CEO, and chairman of Bain & Company, which is based in Boston and has about 19,000 employees globally. The company was founded in 1973.
Before taking on the role in July 2024 and moving to New York, De Vusser was a partner based in Brussels, where he led Bain's private equity practice for Europe, the Middle East, and Africa. De Vusser is the first European to hold the role of worldwide managing partner and CEO, the company said in a 2024 press release.
De Vusser, who first joined Bain in 2000, began his career at the consumer products giant Procter & Gamble, maker of Tide detergent and Crest toothpaste. De Vusser has master's degrees in civil engineering and multilingual business communication from the University of Ghent, according to Bain.
De Vusser's rise to the top role comes as the firm's business is evolving because of tech advances. In December, Bain said tech and "AI-enabled revenue" accounted for 30% of the company's business in 2024. Bain expects that revenue to climb to 50% in the coming years.
In a Bain podcast, De Vusser said the firm's clients are grappling with massive amounts of change, including around artificial intelligence. It's a technology, he said, that's still in its early days.
"It will continue to mature at immense speeds, we believe, in the coming decades," he said on the podcast.
De Vusser has also written about AI. In a recent LinkedIn post, he pointed to Bain research that found fewer than 20% of companies had "meaningfully scaled" generative AI. The reason, he said, is that many organizations tend to view AI "primarily as a technology initiative rather than using it as a catalyst to fundamentally reimagine their business."
For organizations to get it right, De Vusser wrote, they need to simplify key processes, use technology so that it fits with strategic goals, and enable workers to use AI.
Boston Consulting Group — Christoph Schweizer
BCG CEO Christoph Schweizer described his leadership style in a video produced by the company: "Values-led, empathetic, transparent, curious," he says.
The firm elected Schweizer for a second term this year. BCG says its reelection process is "unique." All 1,500 managing directors and partners have an equal vote when choosing a CEO.
Schweizer, who first became CEO in 2021, joined BCG in 1997, according to his biography on the firm's website. He holds an MBA from the University of Texas at Austin's McCombs School of Business and a Bachelor's degree from the WHU Otto Beisheim School of Management in Germany.
During his tenure, BCG has grown in several areas, including the firm's investments in AI — which accounted for bout 20% of the firm's total revenue in 2024 and are expected to grow this year, according to a press release from BCG.
Schweizer has also navigated some controversies during his tenure, including two recent projects related to the Gaza conflict. BCG backed out of a multimillion-dollar American-Israeli project to deliver aid in Gaza that was marked by violence. And two senior BCG leaders were demoted for their role in another project that modeled the potential cost of relocating Palestinians from the territory.
One of the firm's biggest challenges moving forward, Schweizer says in the company interview, will be helping clients embed AI.
"To seize the opportunity, our clients need to fundamentally redefine operating models, value chains, decision-making, and end-to-end processes, while protecting themselves from associated risks, such as info security," he said.
Another major focus for BCG is sustainability, he said.
"Companies and governments will have to get serious about decarbonization extremely fast: setting the right targets, reduction mechanisms, metrics, and enforcement," Schweizer said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Petco
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Petco

Associated Press

time32 minutes ago

  • Associated Press

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Petco

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Petco To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Petco between January 14, 2021 and June 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - July 14, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Petco Health and Wellness Company, Inc. ('Petco' or the 'Company') (NASDAQ: WOOF) and reminds investors of the August 29, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. [ This image cannot be displayed. Please visit the source: ] Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (i) Petco's pandemic-related tailwinds were unsustainable, as was its business model of selling primarily premium and/or high-grade pet food; (ii) accordingly, the strength of Petco's differentiated product strategy was overstated; (iii) Defendants downplayed the true scope and severity of the foregoing issues, the magnitude of changes needed to rectify those issues, and the likely negative impacts of their mitigation strategy on Petco's comparable sales metric; (iv) accordingly, Defendants overstated Petco's ability to deliver sustainable, profitable growth; and (v) as a result, Defendants' public statements were materially false and misleading at all relevant times. On June 5, 2025, Petco issued a press release reporting its financial results for the first quarter of 2025. Among other items, Petco reported net sales of $1.5 billion, representing a 2.3% year-over-year decline. On this news, Petco's stock price fell $0.85 per share, or 23.34%, to close at $2.78 per share on June 6, 2025. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding Petco's conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the Petco class action, go to or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Follow us for updates on LinkedIn, on X, or on Facebook. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner. To view the source version of this press release, please visit

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

Business Wire

timean hour ago

  • Business Wire

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

NEW YORK--(BUSINESS WIRE)-- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Iovance Biotherapeutics, Inc. ('Iovance' or the 'Company') (NASDAQ: IOVA) and reminds investors of the July 14, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi reminds investors of the July 14, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Share Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose the true state of Iovance's growth potential; notably, that it was not equipped to generate and drive demand or was otherwise ill equipped to capitalize upon the purported existing demand for its treatments through its network of approved treatment centers. On July 25, 2024, Iovance announced its financial results for the second quarter of fiscal 2024 and reduced its revenue guidance for the full fiscal year 2024. The Company attributed its results and lowered guidance on 1) 'the iCTC completed annual scheduled maintenance in December' and 'capacity was reduced by more than half for about 1 month,' 2) '[l]ower Proleukin sales' than the company expected, and 3) 'the variable pace at which ATCs began treatment patients.' Investors and analysts reacted immediately to Iovance's revelation. The price of Iovance's common stock declined dramatically. From a closing market price of $3.17 per share on May 8, 2025, Iovance's stock price fell to $1.75 per share on May 9, 2025, a decline of about 44.795% in the span of just a single day. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding Iovance's conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the Iovance class action, go to or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Follow us for updates on LinkedIn, on X, or on Facebook. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

Unusual Machines Announces Pricing of $48.5 Million Registered Direct Offering of Common Stock
Unusual Machines Announces Pricing of $48.5 Million Registered Direct Offering of Common Stock

Miami Herald

time2 hours ago

  • Miami Herald

Unusual Machines Announces Pricing of $48.5 Million Registered Direct Offering of Common Stock

ORLANDO, FL / ACCESS Newswire / July 14, 2025 / Unusual Machines, Inc. (NYSE American:UMAC) (the "Company" or "Unusual Machines"), a leader in drone technology and component manufacturing, today announced it has entered into a securities purchase agreement with certain investors for the purchase and sale of 5,000,000 shares of common stock (or pre-funded warrants in lieu thereof) in a registered direct offering (the "Offering") at a public offering price of $9.70 per share. Dominari Securities LLC is acting as the exclusive placement agent for the Offering. The closing of the Offering is expected to occur on or about July 15, 2025, subject to the satisfaction of customary closing Company expects to receive aggregate gross proceeds of $48.5 million from the Offering, before deducting placement agent fees and other related expenses. The Company intends to use the net proceeds from the Offering to support U.S.-based manufacturing expansion, working capital needs, and general corporate purposes. The common stock (or pre-funded warrants in lieu thereof) will be issued in a registered direct offering pursuant to an effective shelf registration statement on Form S-3 (File No. 333-286413), previously filed with the U.S. Securities and Exchange Commission (the "SEC") and declared effective on April 21, 2025. A prospectus supplement describing the terms of the proposed registered direct offering will be filed with the SEC and once filed, will be available on the SEC's website located at or by contacting Dominari Securities LLC, Attention: Syndicate Department, 725 5th Ave 23 Floor, New York, NY 10022, by email at info@ or by telephone at (212) 393-4500. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About Unusual Machines, Inc. Unusual Machines, Inc. manufactures and sells drone components and drones across a diversified brand portfolio, which includes Fat Shark, the leader in first-person view (FPV) () ultra-low latency video goggles for drone pilots. The Company also retails small, acrobatic FPV drones and equipment directly to consumers through the curated Rotor Riot ecommerce store. With a changing regulatory environment, Unusual Machines seeks to be a dominant Tier-1 parts supplier to the fast-growing multi-billion-dollar U.S. drone industry. According to the global drone accessories market is currently valued at $17.5 billion and is set to top $115 billion by 2032. For more information, please visit Information on the Company's website does not constitute a part of and is not incorporated by reference into this press release. Safe Harbor Statement This press release contains forward-looking statements which involve substantial risks and uncertainties relating to closing the Offering and use of proceeds. Forward-looking statements are often identifiable by the words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "objective," "ongoing," "plan," "predict," "project," "potential," "should," "will," or "would," or the negative of these terms, or other comparable terminology intended to identify statements about the future. These statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. Although the Company believes that it has a reasonable basis for making each forward-looking statement contained in this press release, the Company cautions that these statements are based on a combination of facts and factors currently known by the Company and its expectations of the future, about which the Company cannot be certain. Forward-looking statements are subject to considerable risks and uncertainties, as well as other factors that may cause the Company's actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. These risks and uncertainties include, without limitation, risks and uncertainties related to market conditions; the failure to meet customary closing conditions related to the Offering; and other risks and uncertainties, including those described within the section entitled "Risk Factors" in the Company's 2024 Annual Report on Form 10-K, changes in its business which affect the planned use of proceeds and the Risk Factors contained in the Prospectus Supplement. There can be no assurance that the Company will be able to complete the Offering on the anticipated terms, or at all. The Company undertakes no obligation to update the information contained in this press release to reflect subsequently occurring events or circumstances, except as required by law. Investor Contact: CS Investor Relationsinvestors@ Media Contact: media@ SOURCE: Unusual Machines, Inc.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store